Use of Biosimilars in Pediatric Inflammatory Bowel Disease
Lissy de Ridder(Erasmus MC - Sophia Children’s Hospital), Jorge Amil Dias(Hospital de São João), Caterina Strisciuglio(University of Campania "Luigi Vanvitelli"), Arnold G. Vulto(Erasmus MC), Claudio Romano(University of Messina), Amit Assa(Shaare Zedek Medical Center), Gábor Veres(Southwest General Health Center), Jiří Bronský(Charles University), Almuthe Hauer(Medical University of Graz), Richard K. Russell(Tel Aviv University), Nadeem Afzal(University Hospital Southampton NHS Foundation Trust), D. Knafelz(Bambino Gesù Children's Hospital), Harland S. Winter(Massachusetts General Hospital), Victorien M. Wolters(University Medical Center Utrecht), Paolo Lionetti(Meyer Children's Hospital), Małgorzata Sładek(Jagiellonian University)
Cited by 49
Related Papers
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
|Proceedings of the National Academy of Sciences|2010|5.6k
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
|Science|2009|1.5k
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
|Journal of Pediatric Gastroenterology and Nutrition|2013|1.4k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k